SNX-482
SNX-482 is a peptide derived from the venom of the tarantula species Hysterocrates gigas. It is a potent and selective blocker of the alpha1E subunit of the voltage-gated calcium channel.
Structure[edit | edit source]
SNX-482 is a 41-amino acid peptide with three disulfide bonds. It has a unique structural motif that includes a triple-stranded beta-sheet and a single alpha-helix.
Function[edit | edit source]
SNX-482 selectively blocks the alpha1E subunit of the voltage-gated calcium channel, which is primarily expressed in the central nervous system. This blocking action can inhibit the flow of calcium ions into cells, which can affect various cellular functions.
Clinical significance[edit | edit source]
Due to its ability to selectively block certain calcium channels, SNX-482 has potential therapeutic applications in the treatment of neuropathic pain, epilepsy, and cardiac arrhythmias. However, further research is needed to fully understand its mechanisms of action and potential side effects.
See also[edit | edit source]
References[edit | edit source]
SNX-482 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD